Genovoxx GmbH
Records under this name other than patents Genovoxx GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Genovoxx GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,637,650 | Macromolecular Nucleotide Compounds and Methods for Using the Same Formerly held Term ended Term ended Sep 9, 2026 · High confidence | Term ended | Term ended Sep 9, 2026 | High confidence |
| US 9,035,035 | Macromolecular Nucleotide Compounds and Methods for Using the Same Formerly held Term ended Term ended Sep 9, 2026 · Medium confidence | Term ended | Term ended Sep 9, 2026 | Medium confidence |
| US 9,315,860 | Conjugates of nucleotides and method for the application thereof Formerly held Lapsed on the fee record Ended Apr 19, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2024 | USPTO record |
| US 9,994,894 | Method and components for detecting nucleic acid chains Formerly held Lapsed on the fee record Ended Jun 12, 2022 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2022 | USPTO record |